Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Marrow Neoplasms × darinaparsin × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma 2 Hematologic Neoplasms 2 Recurrence 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Bone Marrow Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421213 2012-07-19

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Alaunos Therapeutics

Phase 2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Bone Marrow Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡